Addiction & Behavioral Health

Smoking Cessation

Smoking remains one of the leading causes of preventable disease worldwide. CenExel is committed to advancing innovative smoking cessation therapies through scientifically driven clinical research. We partner with sponsors to evaluate new treatments that help individuals reduce nicotine dependence, improve long-term health outcomes, and support lasting recovery across adult populations.

Studies Conducted
0 +
Trial Participants
0 +
Active Sites
0 +
Overview

Advancing Smoking Cessation Research

CenExel conducts specialized smoking cessation clinical trials focused on nicotine addiction, behavioral therapies, and emerging treatment solutions. Our experienced investigators and operational teams ensure efficient study execution while prioritizing patient safety, retention, and long-term treatment success.

Evidence-Based Treatment Research

We evaluate innovative therapies designed to reduce nicotine cravings and support sustained smoking cessation.

Diverse Patient Recruitment

Our nationwide network helps recruit broad patient populations for more inclusive and accurate clinical outcomes.
Conditions Covered

Smoking Cessation Conditions We Research

Our smoking cessation research programs support a wide range of nicotine dependence and behavioral addiction studies.

  • Nicotine Dependence
  • Tobacco Addiction
  • E-Cigarette Cessation
  • Vaping Dependence
  • Relapse Prevention
  • Behavioral Addiction Support
  • Craving Reduction Therapy
  • Nicotine Withdrawal Symptoms
Our Approach

Why Sponsors Choose CenExel for Smoking Cessation

CenExel delivers experienced clinical operations, strong patient recruitment capabilities, and high-quality data collection to support smoking cessation and addiction-focused research programs.

01

Targeted Patient Recruitment

Our nationwide recruitment strategies help identify motivated participants for smoking cessation studies.

02

Behavioral Health Expertise

Experienced investigators specialize in addiction medicine and behavioral health clinical research.

03

Retention-Focused Programs

Patient engagement strategies improve compliance and long-term study participation.

04

Fast Study Activation

Efficient site activation and operational execution help sponsors accelerate timelines.

Phase Coverage

Supported Smoking Cessation Trial Phases

CenExel supports smoking cessation and nicotine dependence studies from early proof-of-concept trials through large-scale Phase IV programs.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our clinical sites support behavioral therapy studies, medication-based smoking cessation trials, nicotine replacement research, and digital therapeutic programs.

Smoking Cessation Task Force

CenExel supports smoking cessation studies focused on nicotine dependence, vaping addiction, relapse prevention, and behavioral treatment strategies for adult and adolescent populations.

Active Sites

18 Sites

CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg

Our Blog